nox-100
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2012 (NCT01672008)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Nitric-oxide synthase, brainINHIBITOR
NOS1 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CN(C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C(=S)[S-].[Na+]- Mol. weight
- 293.34 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4301787 ↗
- ChEMBLCHEMBL4297472 ↗
Also known as
- nox-100
- nox-100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01672008 | Phase 2 | Aug 1, 2012 | Medinox, Inc., Orient Europharma Co., Ltd. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medinox, Inc. | For profit | 1 | 1 | 1 | 2012 |
| Orient Europharma Co., Ltd. | For profit | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1